Drug profile · INN
chlortetracycline hydrochloride
AUREOMYCIN
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
chlortetracycline hydrochloride (AUREOMYCIN) is an FDA-listed pharmaceutical active ingredient. Route of administration: ophthalmic. Current US regulatory status: approved.
Key facts
INN chlortetracycline hydrochloride
Brand AUREOMYCIN
Route OPHTHALMIC
Formulation OINTMENT
Frequently asked questions
What is chlortetracycline hydrochloride?
chlortetracycline hydrochloride (AUREOMYCIN) is an FDA-listed pharmaceutical active ingredient. Route of administration: ophthalmic. Current US regulatory status: approved.
What is the brand name for chlortetracycline hydrochloride?
AUREOMYCIN is a marketed brand name for chlortetracycline hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of chlortetracycline hydrochloride?
chlortetracycline hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.